PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
12-Nov-2020 KAHR Announces First Patient Dosed in Phase 1/2 Clinical Trial of DSP107, Bi-Functional CD47x41BB Candidate for the Treatment of Solid Tumors KAHR Medical
12-Nov-2020 A-LabInsider launched an app to boost biotech businesses A-LabInsider
12-Nov-2020 ONK Therapeutics Opens US R&D Operations and Appoints Head of R&D, USA ONK Therapeutics
12-Nov-2020 PureTech Founded Entity Vor Biopharma Announces Exclusive License of Clinical-Stage CD33 CAR-T from National Cancer Institute PureTech Health plc
12-Nov-2020 Belgian biotech Apaxen appoints Bart Wuurman as CEO Apaxen
12-Nov-2020 Tiziana Life Sciences announces collaboration with Parexel Biotech to conduct phase 1b/2 clinical trial in patients with Crohn’s Disease Tiziana Life Sciences
12-Nov-2020 Rexgenero-France to present Off-the-Shelf CAR-T Therapy nanoparticle data at PEGS Europe 2020 Rexgenero-France
12-Nov-2020 UCB strengthens its gene therapy activities with additional pipeline programs, capabilities and platforms UCB
12-Nov-2020 XJTLU launches new Academy of Pharmacy Xi'an Jiaotong-Liverpool University
12-Nov-2020 PSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. - BIIB Pomerantz LLP
11-Nov-2020 Inhibrx Announces Positive Interim Results from the Phase 1 Trial of INBRX-109 in Chondrosarcoma Patients Inhibrx, Inc.
11-Nov-2020 Heron Therapeutics to Present at Several Upcoming Virtual Investor Conferences Heron Therapeutics, Inc.
11-Nov-2020 SenesTech Restructures Board for Commercial Growth SenesTech, Inc.
11-Nov-2020 Oncolytics Biotech® Reports 2020 Third Quarter Development Highlights and Financial Results Oncolytics Biotech® Inc.
11-Nov-2020 Oncolytics Biotech® Reports 2020 Third Quarter Development Highlights and Financial Results Oncolytics Biotech® Inc.
11-Nov-2020 Epigenetics Market Size is Projected To Reach USD 2,168 Million By 2027 - Valuates Reports Valuates Reports
11-Nov-2020 Angiocrine Bioscience Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to AB-205 (Universal E-CEL® Cell Therapy) to Treat Organ Vascular Niche Injuries for the Prevention of Severe Toxicities in Lymphoma Patients undergoing Curative High-Dose Therapy with Autologous Stem Cell Transplantation Angiocrine Bioscience, Inc.
11-Nov-2020 Co-Diagnostics, Inc. CoPrimers(TM) Shown to be Effective in COVID-19 Saliva PCR Tests Without Sample Extraction Co-Diagnostics
11-Nov-2020 SciBite launches SciBiteAI Relationship Extraction models SciBite
10-Nov-2020 Liminal Biosciences to Reschedule Reporting of Q3 2020 Results and Conference Call Liminal BioSciences Inc.